FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3010025922> ?p ?o ?g. }

• W3010025922 abstract "This study compared the effectiveness and safety of postoperative concurrent chemoradiotherapy (POCRT) containing paclitaxel (PTX) and cisplatin (DDP) with postoperative radiotherapy (PORT) after R0 resection for stage II-III thoracic esophageal squamous cell carcinoma (TESCC).After propensity score matching (PSM) analysis, 87 TESCC patients treated with PORT were matched 1:1 to 87 patients who received POCRT between July 2012 and December 2018. Radiotherapy was delivered at a dose of 200 cGy per day to a total dose of 5000 cGy. Concurrent chemotherapy consisted of DDP (25 mg/m2) for 3 days plus PTX (135 mg/m2) on day 1 every 3 weeks.Patient- and disease-related characteristics were well-balanced between the two groups. The median overall survival (OS) and disease-free survival (DFS) times were 39.2 and 31.0 months, respectively. The 5-year OS and DFS rates were 31.9% and 19.1% in the PORT group and 45.1% and 35.1% in the POCRT group, respectively. Statistical significance was demonstrated by comparing OS and DFS (P=0.022 and 0.016, respectively). Additionally, subgroup analysis revealed that in node positive TESCC patients, the POCRT group was significantly different from the PORT group regarding OS and DFS (P=0.049 and 0.039, respectively). POCRT decreased distant metastasis over PORT (P=0.044) with manageable toxicities. Multivariate analysis revealed that aside from factors associated with tumor stages, treatment modality was another strong prognostic factor for both OS and DFS (P=0.015 and 0.010, respectively).Stage II-III TESCC patients could benefit from POCRT with manageable toxicities. Future well-designed prospective studies are highly warranted to confirm the findings in our report." @default.
• W3010025922 created "2020-03-13" @default.
• W3010025922 creator A5008581844 @default.
• W3010025922 creator A5031620134 @default.
• W3010025922 creator A5041614957 @default.
• W3010025922 creator A5050573989 @default.
• W3010025922 creator A5069216833 @default.
• W3010025922 creator A5079378167 @default.
• W3010025922 date "2020-03-01" @default.
• W3010025922 modified "2023-09-27" @default.
• W3010025922 title "<p>The Role of Adjuvant Chemoradiotherapy Over Radiotherapy After R0 Resection for Stage II-III Esophageal Squamous Cell Carcinoma</p>" @default.
• W3010025922 cites W121116978 @default.
• W3010025922 cites W1504366907 @default.
• W3010025922 cites W1998852550 @default.
• W3010025922 cites W2026986976 @default.
• W3010025922 cites W2073132357 @default.
• W3010025922 cites W2094277584 @default.
• W3010025922 cites W2116964952 @default.
• W3010025922 cites W2117907121 @default.
• W3010025922 cites W2121179326 @default.
• W3010025922 cites W2127996441 @default.
• W3010025922 cites W2143000178 @default.
• W3010025922 cites W2150989592 @default.
• W3010025922 cites W2154444715 @default.
• W3010025922 cites W2169906597 @default.
• W3010025922 cites W2169961966 @default.
• W3010025922 cites W2219978888 @default.
• W3010025922 cites W2272984102 @default.
• W3010025922 cites W2274428375 @default.
• W3010025922 cites W2416055129 @default.
• W3010025922 cites W2724177236 @default.
• W3010025922 cites W2736561915 @default.
• W3010025922 cites W2791556962 @default.
• W3010025922 cites W2924885678 @default.
• W3010025922 cites W4231908668 @default.
• W3010025922 doi "https://doi.org/10.2147/cmar.s232930" @default.
• W3010025922 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7062396" @default.
• W3010025922 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32184666" @default.
• W3010025922 hasPublicationYear "2020" @default.
• W3010025922 type Work @default.
• W3010025922 sameAs 3010025922 @default.
• W3010025922 citedByCount "5" @default.
• W3010025922 countsByYear W30100259222021 @default.
• W3010025922 countsByYear W30100259222022 @default.
• W3010025922 crossrefType "journal-article" @default.
• W3010025922 hasAuthorship W3010025922A5008581844 @default.
• W3010025922 hasAuthorship W3010025922A5031620134 @default.
• W3010025922 hasAuthorship W3010025922A5041614957 @default.
• W3010025922 hasAuthorship W3010025922A5050573989 @default.
• W3010025922 hasAuthorship W3010025922A5069216833 @default.
• W3010025922 hasAuthorship W3010025922A5079378167 @default.
• W3010025922 hasBestOaLocation W30100259221 @default.
• W3010025922 hasConcept C119599485 @default.
• W3010025922 hasConcept C121608353 @default.
• W3010025922 hasConcept C126322002 @default.
• W3010025922 hasConcept C127413603 @default.
• W3010025922 hasConcept C143998085 @default.
• W3010025922 hasConcept C146357865 @default.
• W3010025922 hasConcept C151730666 @default.
• W3010025922 hasConcept C17923572 @default.
• W3010025922 hasConcept C2776694085 @default.
• W3010025922 hasConcept C2777292972 @default.
• W3010025922 hasConcept C2777863537 @default.
• W3010025922 hasConcept C2778424827 @default.
• W3010025922 hasConcept C2779742542 @default.
• W3010025922 hasConcept C2780091936 @default.
• W3010025922 hasConcept C32802771 @default.
• W3010025922 hasConcept C509974204 @default.
• W3010025922 hasConcept C71924100 @default.
• W3010025922 hasConcept C86803240 @default.
• W3010025922 hasConcept C90924648 @default.
• W3010025922 hasConceptScore W3010025922C119599485 @default.
• W3010025922 hasConceptScore W3010025922C121608353 @default.
• W3010025922 hasConceptScore W3010025922C126322002 @default.
• W3010025922 hasConceptScore W3010025922C127413603 @default.
• W3010025922 hasConceptScore W3010025922C143998085 @default.
• W3010025922 hasConceptScore W3010025922C146357865 @default.
• W3010025922 hasConceptScore W3010025922C151730666 @default.
• W3010025922 hasConceptScore W3010025922C17923572 @default.
• W3010025922 hasConceptScore W3010025922C2776694085 @default.
• W3010025922 hasConceptScore W3010025922C2777292972 @default.
• W3010025922 hasConceptScore W3010025922C2777863537 @default.
• W3010025922 hasConceptScore W3010025922C2778424827 @default.
• W3010025922 hasConceptScore W3010025922C2779742542 @default.
• W3010025922 hasConceptScore W3010025922C2780091936 @default.
• W3010025922 hasConceptScore W3010025922C32802771 @default.
• W3010025922 hasConceptScore W3010025922C509974204 @default.
• W3010025922 hasConceptScore W3010025922C71924100 @default.
• W3010025922 hasConceptScore W3010025922C86803240 @default.
• W3010025922 hasConceptScore W3010025922C90924648 @default.
• W3010025922 hasLocation W30100259221 @default.
• W3010025922 hasLocation W30100259222 @default.
• W3010025922 hasLocation W30100259223 @default.
• W3010025922 hasLocation W30100259224 @default.
• W3010025922 hasOpenAccess W3010025922 @default.
• W3010025922 hasPrimaryLocation W30100259221 @default.
• W3010025922 hasRelatedWork W12707773 @default.
• W3010025922 hasRelatedWork W16137470 @default.
• W3010025922 hasRelatedWork W19418258 @default.
• W3010025922 hasRelatedWork W3582852 @default.

• next